Abstract
Antiretroviral drug resistance was evaluated in 88 adults infected with human immunodeficiency virus, most with subtype CRF11_cpx, who had received a first-line antiretroviral regimen for 6 months, in N'Djamena, Chad. A total of 47 patients (53%) had detectable viral load at month 6, and 56 (64%) had at least 1 antiretroviral resistance mutation observed.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-HIV Agents / therapeutic use*
-
Antiretroviral Therapy, Highly Active*
-
Chad
-
Drug Resistance, Viral*
-
HIV Infections / drug therapy*
-
HIV Infections / virology*
-
HIV-1 / drug effects*
-
HIV-1 / isolation & purification
-
Humans
-
Molecular Sequence Data
-
Mutation, Missense
-
RNA, Viral / genetics
-
Sequence Analysis, DNA
-
Young Adult
Substances
-
Anti-HIV Agents
-
RNA, Viral
Associated data
-
GENBANK/FJ688173
-
GENBANK/FJ688174
-
GENBANK/FJ688175
-
GENBANK/FJ688176
-
GENBANK/FJ688177
-
GENBANK/FJ688178
-
GENBANK/FJ688179
-
GENBANK/FJ688180
-
GENBANK/FJ688181
-
GENBANK/FJ688182
-
GENBANK/FJ688183
-
GENBANK/FJ688184
-
GENBANK/FJ688185
-
GENBANK/FJ688186
-
GENBANK/FJ688187
-
GENBANK/FJ688188
-
GENBANK/FJ688189
-
GENBANK/FJ688190
-
GENBANK/FJ688191
-
GENBANK/FJ688192
-
GENBANK/FJ688193
-
GENBANK/FJ688194
-
GENBANK/FJ688195
-
GENBANK/FJ688196
-
GENBANK/FJ688197
-
GENBANK/FJ688198
-
GENBANK/FJ688199
-
GENBANK/FJ688200
-
GENBANK/FJ688201
-
GENBANK/FJ688202
-
GENBANK/FJ688203
-
GENBANK/FJ688204
-
GENBANK/FJ688205
-
GENBANK/FJ688206
-
GENBANK/FJ688207
-
GENBANK/FJ688208
-
GENBANK/FJ688209